Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Kenvue Inc. Common Stock (KVUE) vs Tilray Brands Inc (TLRY) Price & Performance

Kenvue Inc. Common StockTrade
Tilray Brands IncTrade

Price performance (Past 24H)

Key statistics

Kenvue Inc. Common Stock vs Tilray Brands Inc — how do they compare? Kenvue Inc. Common Stock trades at $17.68 (market cap $34.06B), while Tilray Brands Inc trades at $3.54 (market cap $530.54M). The key difference: Kenvue Inc. Common Stock is far larger — about 64.2× Tilray Brands Inc's market cap, and Kenvue Inc. Common Stock pays a 4.74% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals.

KVUETLRY
Market Cap
$34.06B$530.54M
Volume
23,267,2289,099,075
Sector
Consumer StaplesHealth
52-Week High
$19.83$21.00
52-Week Low
$14.11$3.57
Enterprise Value
$41.56B$684.46M
Dividend Yield
4.74%—
Typical Hold Time
—31 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Kenvue Inc. Common Stock

No Aura AI signal available yet.

Tilray Brands Inc

TLRY trades at $3.54, down 4.71% on the day and near 52-week lows, reflecting persistent bearish sentiment. The stock shows negative technical momentum with consecutive earnings misses and widening losses despite revenue growth. Recent financials reveal a net loss of $2.19B for 2025, though analyst consensus maintains a $65.01 price target with 25% buy ratings. Business developments include new product launches and leadership changes under Tilray's expanded beverage portfolio.

Outlook remains challenged by profitability concerns and high debt, but potential cannabis regulatory shifts could catalyze recovery. Investment opportunity hinges on execution improvement and market expansion, while risks include sustained cash burn and competitive pressures in the cannabis sector.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

KVUE

No sentiment data available yet.

TLRY
54% Buy46% Sell
Avg holding period · 31 Days

Top news

Latest headlines on both assets

About Kenvue Inc. Common Stock

Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.

Read more on KVUE →

About Tilray Brands Inc

Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.

Read more on TLRY →